IBDEI0MD ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,10979,1,4,0)
 ;;=4^PERS. CONS FOR ANOTHER
 ;;^UTILITY(U,$J,358.3,10979,2)
 ;;=^329985
 ;;^UTILITY(U,$J,358.3,10980,0)
 ;;=V72.5^^70^718^14
 ;;^UTILITY(U,$J,358.3,10980,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10980,1,3,0)
 ;;=3^V72.5
 ;;^UTILITY(U,$J,358.3,10980,1,4,0)
 ;;=4^RADIOLOGICAL EXAM NEC
 ;;^UTILITY(U,$J,358.3,10980,2)
 ;;=^276359
 ;;^UTILITY(U,$J,358.3,10981,0)
 ;;=V81.2^^70^718^17
 ;;^UTILITY(U,$J,358.3,10981,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10981,1,3,0)
 ;;=3^V81.2
 ;;^UTILITY(U,$J,358.3,10981,1,4,0)
 ;;=4^SCREEN-CARDIOVASC NEC
 ;;^UTILITY(U,$J,358.3,10981,2)
 ;;=^295689
 ;;^UTILITY(U,$J,358.3,10982,0)
 ;;=V77.1^^70^718^18
 ;;^UTILITY(U,$J,358.3,10982,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10982,1,3,0)
 ;;=3^V77.1
 ;;^UTILITY(U,$J,358.3,10982,1,4,0)
 ;;=4^SCREEN-DIABETES MELLITUS
 ;;^UTILITY(U,$J,358.3,10982,2)
 ;;=^295662
 ;;^UTILITY(U,$J,358.3,10983,0)
 ;;=V80.3^^70^718^19
 ;;^UTILITY(U,$J,358.3,10983,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10983,1,3,0)
 ;;=3^V80.3
 ;;^UTILITY(U,$J,358.3,10983,1,4,0)
 ;;=4^SCREEN-EAR DISEASE
 ;;^UTILITY(U,$J,358.3,10983,2)
 ;;=^295686
 ;;^UTILITY(U,$J,358.3,10984,0)
 ;;=V77.91^^70^718^21
 ;;^UTILITY(U,$J,358.3,10984,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10984,1,3,0)
 ;;=3^V77.91
 ;;^UTILITY(U,$J,358.3,10984,1,4,0)
 ;;=4^SCREEN-LIPOID DISORDERS
 ;;^UTILITY(U,$J,358.3,10984,2)
 ;;=^322093
 ;;^UTILITY(U,$J,358.3,10985,0)
 ;;=V82.0^^70^718^23
 ;;^UTILITY(U,$J,358.3,10985,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10985,1,3,0)
 ;;=3^V82.0
 ;;^UTILITY(U,$J,358.3,10985,1,4,0)
 ;;=4^SCREEN-SKIN DISEASE
 ;;^UTILITY(U,$J,358.3,10985,2)
 ;;=^295694
 ;;^UTILITY(U,$J,358.3,10986,0)
 ;;=V74.1^^70^718^24
 ;;^UTILITY(U,$J,358.3,10986,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10986,1,3,0)
 ;;=3^V74.1
 ;;^UTILITY(U,$J,358.3,10986,1,4,0)
 ;;=4^SCREEN-TB
 ;;^UTILITY(U,$J,358.3,10986,2)
 ;;=^108715
 ;;^UTILITY(U,$J,358.3,10987,0)
 ;;=V82.89^^70^718^22
 ;;^UTILITY(U,$J,358.3,10987,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10987,1,3,0)
 ;;=3^V82.89
 ;;^UTILITY(U,$J,358.3,10987,1,4,0)
 ;;=4^SCREEN-OTH SPECIFIED CONDITIONS
 ;;^UTILITY(U,$J,358.3,10987,2)
 ;;=^322099
 ;;^UTILITY(U,$J,358.3,10988,0)
 ;;=V81.1^^70^718^20
 ;;^UTILITY(U,$J,358.3,10988,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10988,1,3,0)
 ;;=3^V81.1
 ;;^UTILITY(U,$J,358.3,10988,1,4,0)
 ;;=4^SCREEN-HYPERTENSION
 ;;^UTILITY(U,$J,358.3,10988,2)
 ;;=^295688
 ;;^UTILITY(U,$J,358.3,10989,0)
 ;;=V65.41^^70^719^1
 ;;^UTILITY(U,$J,358.3,10989,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10989,1,3,0)
 ;;=3^V65.41
 ;;^UTILITY(U,$J,358.3,10989,1,4,0)
 ;;=4^EXERCISE
 ;;^UTILITY(U,$J,358.3,10990,0)
 ;;=V65.44^^70^719^2
 ;;^UTILITY(U,$J,358.3,10990,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10990,1,3,0)
 ;;=3^V65.44
 ;;^UTILITY(U,$J,358.3,10990,1,4,0)
 ;;=4^HIV
 ;;^UTILITY(U,$J,358.3,10991,0)
 ;;=V65.43^^70^719^3
 ;;^UTILITY(U,$J,358.3,10991,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10991,1,3,0)
 ;;=3^V65.43
 ;;^UTILITY(U,$J,358.3,10991,1,4,0)
 ;;=4^INJURY PREVENTION
 ;;^UTILITY(U,$J,358.3,10992,0)
 ;;=V65.8^^70^719^5
 ;;^UTILITY(U,$J,358.3,10992,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10992,1,3,0)
 ;;=3^V65.8
 ;;^UTILITY(U,$J,358.3,10992,1,4,0)
 ;;=4^SEXUAL TRAUMA
 ;;^UTILITY(U,$J,358.3,10993,0)
 ;;=V65.49^^70^719^4
 ;;^UTILITY(U,$J,358.3,10993,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10993,1,3,0)
 ;;=3^V65.49
 ;;^UTILITY(U,$J,358.3,10993,1,4,0)
 ;;=4^MEDICATION COUNSELING
 ;;^UTILITY(U,$J,358.3,10993,2)
 ;;=^303471
 ;;^UTILITY(U,$J,358.3,10994,0)
 ;;=V87.39^^70^720^1
